These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28414299)
41. Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum. Doig NM; Moss J; Bolam JP J Neurosci; 2010 Nov; 30(44):14610-8. PubMed ID: 21048118 [TBL] [Abstract][Full Text] [Related]
42. CTTNBP2 Controls Synaptic Expression of Zinc-Related Autism-Associated Proteins and Regulates Synapse Formation and Autism-like Behaviors. Shih PY; Hsieh BY; Lin MH; Huang TN; Tsai CY; Pong WL; Lee SP; Hsueh YP Cell Rep; 2020 Jun; 31(9):107700. PubMed ID: 32492416 [TBL] [Abstract][Full Text] [Related]
43. ∆FosB differentially modulates nucleus accumbens direct and indirect pathway function. Grueter BA; Robison AJ; Neve RL; Nestler EJ; Malenka RC Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1923-8. PubMed ID: 23319622 [TBL] [Abstract][Full Text] [Related]
44. Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. Weston MC; Chen H; Swann JW J Neurosci; 2012 Aug; 32(33):11441-52. PubMed ID: 22895726 [TBL] [Abstract][Full Text] [Related]
45. The role of selected postsynaptic scaffolding proteins at glutamatergic synapses in autism-related animal models. Meliskova V; Havranek T; Bacova Z; Bakos J J Integr Neurosci; 2021 Dec; 20(4):1047-1057. PubMed ID: 34997728 [TBL] [Abstract][Full Text] [Related]
46. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism. Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190 [TBL] [Abstract][Full Text] [Related]
47. Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors. Lambot L; Chaves Rodriguez E; Houtteman D; Li Y; Schiffmann SN; Gall D; de Kerchove d'Exaerde A J Neurosci; 2016 May; 36(18):4976-92. PubMed ID: 27147651 [TBL] [Abstract][Full Text] [Related]
48. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Lovinger DM Neuropharmacology; 2010 Jun; 58(7):951-61. PubMed ID: 20096294 [TBL] [Abstract][Full Text] [Related]
49. An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio. Sadybekov A; Tian C; Arnesano C; Katritch V; Herring BE Nat Commun; 2017 Sep; 8(1):601. PubMed ID: 28928363 [TBL] [Abstract][Full Text] [Related]
50. A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders. Bagni C; Zukin RS Neuron; 2019 Mar; 101(6):1070-1088. PubMed ID: 30897358 [TBL] [Abstract][Full Text] [Related]
51. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture. Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815 [TBL] [Abstract][Full Text] [Related]
52. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation. Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589 [TBL] [Abstract][Full Text] [Related]
53. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Allen PB; Zachariou V; Svenningsson P; Lepore AC; Centonze D; Costa C; Rossi S; Bender G; Chen G; Feng J; Snyder GL; Bernardi G; Nestler EJ; Yan Z; Calabresi P; Greengard P Neuroscience; 2006 Jul; 140(3):897-911. PubMed ID: 16600521 [TBL] [Abstract][Full Text] [Related]
54. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Welch JM; Lu J; Rodriguiz RM; Trotta NC; Peca J; Ding JD; Feliciano C; Chen M; Adams JP; Luo J; Dudek SM; Weinberg RJ; Calakos N; Wetsel WC; Feng G Nature; 2007 Aug; 448(7156):894-900. PubMed ID: 17713528 [TBL] [Abstract][Full Text] [Related]
55. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment. Costales JL; Kolevzon A Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671 [TBL] [Abstract][Full Text] [Related]
57. Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength. Arons MH; Lee K; Thynne CJ; Kim SA; Schob C; Kindler S; Montgomery JM; Garner CC J Neurosci; 2016 Aug; 36(35):9124-34. PubMed ID: 27581454 [TBL] [Abstract][Full Text] [Related]
58. Dendritic spine actin cytoskeleton in autism spectrum disorder. Joensuu M; Lanoue V; Hotulainen P Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):362-381. PubMed ID: 28870634 [TBL] [Abstract][Full Text] [Related]
59. Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum. Song C; Anderson GR; Sutton LP; Dao M; Martemyanov KA J Neurosci; 2018 Aug; 38(32):7120-7131. PubMed ID: 30006367 [TBL] [Abstract][Full Text] [Related]